Amber Rivas

Avivia is a Dutch independent pharmaceutical R&D service organization and your partner in drug (re)formulation, repurposing and repositioning. Avivia is specialized in medicinal product development. From product evaluation to comprehensive formulation and analytical development, excipient characterisation, defomulation, dissolution test development, stability studies, IMPD production, CMO selection and transfer. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). Avivia has four complementary pharmaceutical R&D speciality service platforms: - Pharmaceutical R&D Services - Analytical R&D Services - Dissolution Lab Services - Excipia ™ Avivia for all Big Pharma, speciality pharma, drug development firms, generic drug companies, universities, law firms, excipient manufacturers and even venture capital firms… our customer base is very broad and diverse. IP Protection, creation and evasion Be it the protection or creation of new formulation patents for originator products or the evasion of established formulation patents for generic drug development, we are constantly seeking new IP opportunities to maximize product value. Network to accelerate Avivia has access to a great team of pharmaceutical and analytical development professionals as well as to state-of-the-art laboratory infrastructure and equipment. We have also developed a large network or preferred partners in other fields such as pre-clinical development, GMP manufacturing and regulatory affairs. Excipia. Excipia is our excipient knowledge platform focused on excipient related troubleshooting, characterization and reversed engineering, see our dedicated website https://www.excipia.eu. If you are interested to learn more about Avivia, don’t hesitate to contact us and we would be happy to help you accelerating your development programs!